Meningococcal Vaccines Market Report

Europe Meningococcal Vaccines Market Size, Status and Forecast 2014-2026

  • POSTDATE：Jun 18, 2020
  • PAGES：183
  • REPORT CODE：GMM551862
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • The Meningococcal Vaccines market was valued at XX.0 Million US$ in 2018 and is projected to reach XX.0 Million US$ by 2026, at a CAGR (Compound Annual Growth Rate) of 13.1% during the forecast period. Focusing on the Europe market, this report analyzes the specific consumption structure, such as types and end users. In order to present the status of the circulation of this product in different Europe countries, this report covers top export and import countries to confirm the potential markets. Leading countries such as Germany, UK, France, Italy, Spain, Poland, Russia, Switzerland, Turkey, Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden), Benelux (Belgium, Netherlands, and Luxembourg), Baltic States (Estonia, Latvia, and Lithuania) and other countries, the market status and consumption potential of these countries are covered in the research, providing valuable opinions of strategic adjustments for existing groups and new entrants.

    The Snapshot of Europe Meningococcal Vaccines Market Segmentations:

    By Player:

    • Sanofi

    • Pfizer

    • Baxter International

    • JN-International Medical

    • Novartis International

    • GlaxoSmithKline

    By Type:

    • Menactra

    • Menomune

    By End-User:

    • Pneumonia

    • Meningitis

    • Bacteremia

    • Others (Arthritis, Conjunctivitis, Urethritis)

    By Region:

    • Germany

    • UK

    • France

    • Italy

    • Spain

    • Poland

    • Russia

    • Switzerland

    • Turkey

    • Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden)

      • Denmark

      • Finland

      • Norway

      • Sweden

      • Iceland

    • Benelux (Belgium, Netherlands, and Luxembourg)

      • Belgium

      • Netherlands

      • Luxembourg

    • Baltic States (Estonia, Latvia, and Lithuania)

      • Estonia

      • Latvia

      • Lithuania

  • Table of Contents

    1 Report Overview

    • 1.1 Product Definition and Scope

    • 1.2 PEST (Political, Economic, Social and Technological) Analysis of Meningococcal Vaccines Market

    • 1.3 Market Segment by Type

    • 1.3.1 Europe Meningococcal Vaccines Market Size and Growth Rate of Menactra from 2014 to 2026

    • 1.3.2 Europe Meningococcal Vaccines Market Size and Growth Rate of Menomune from 2014 to 2026

    • 1.4 Market Segment by Application

    • 1.4.1 Europe Meningococcal Vaccines Market Size and Growth Rate of Pneumonia from 2014 to 2026

    • 1.4.2 Europe Meningococcal Vaccines Market Size and Growth Rate of Meningitis from 2014 to 2026

    • 1.4.3 Europe Meningococcal Vaccines Market Size and Growth Rate of Bacteremia from 2014 to 2026

    • 1.4.4 Europe Meningococcal Vaccines Market Size and Growth Rate of Others (Arthritis, Conjunctivitis, Urethritis) from 2014 to 2026

    • 1.5 Market Segment by Regions

      • 1.5.1 Germany Meningococcal Vaccines Market Size and Growth Rate from 2014 to 2026

      • 1.5.2 UK Meningococcal Vaccines Market Size and Growth Rate from 2014 to 2026

      • 1.5.3 France Meningococcal Vaccines Market Size and Growth Rate from 2014 to 2026

      • 1.5.4 Italy Meningococcal Vaccines Market Size and Growth Rate from 2014 to 2026

      • 1.5.5 Spain Meningococcal Vaccines Market Size and Growth Rate from 2014 to 2026

      • 1.5.6 Poland Meningococcal Vaccines Market Size and Growth Rate from 2014 to 2026

      • 1.5.7 Russia Meningococcal Vaccines Market Size and Growth Rate from 2014 to 2026

      • 1.5.8 Switzerland Meningococcal Vaccines Market Size and Growth Rate from 2014 to 2026

      • 1.5.9 Turkey Meningococcal Vaccines Market Size and Growth Rate from 2014 to 2026

      • 1.5.10 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Meningococcal Vaccines Market Size and Growth Rate from 2014 to 2026

      • 1.5.11 Benelux (Belgium, Netherlands, and Luxembourg) Meningococcal Vaccines Market Size and Growth Rate from 2014 to 2026

      • 1.5.12 Baltic States (Estonia, Latvia, and Lithuania) Meningococcal Vaccines Market Size and Growth Rate from 2014 to 2026

    2 Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Market Challenges and Restraints

      • 2.1.2 Market Opportunities and Potentials

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape Analysis

      • 2.2.1 Industrial Concentration Analysis

      • 2.2.2 Porter's Five Forces Analysis of the Industry

      • 2.2.3 SWOT Analysis for New Entrants

    3 Segmentation of Meningococcal Vaccines Market by Types

    • 3.1 Products Development Trends of Different Types

    • 3.2 Commercial Products Types of Major Venders

    • 3.3 Competitive Landscape Analysis of Different Types

    • 3.4 Market Size of Meningococcal Vaccines by Major Types

      • 3.4.1 Market Size and Growth Rate of Menactra

      • 3.4.2 Market Size and Growth Rate of Menomune

    4 Segmentation of Meningococcal Vaccines Market by End-Users

    • 4.1 Downstream Client Analysis by End-Users

    • 4.2 Competitive Landscape Analysis of Different End-Users

    • 4.3 Market Potential Analysis of Different End-Users

    • 4.4 Market Size of Meningococcal Vaccines by Major End-Users

      • 4.4.1 Market Size and Growth Rate of Pneumonia for Construction

      • 4.4.2 Market Size and Growth Rate of Meningitis for Construction

      • 4.4.3 Market Size and Growth Rate of Bacteremia for Construction

      • 4.4.4 Market Size and Growth Rate of Others (Arthritis, Conjunctivitis, Urethritis) for Construction

    5 Market Analysis by Major Regions

    • 5.1 Europe Meningococcal Vaccines Production Analysis by Top Regions

    • 5.2 Europe Meningococcal Vaccines Consumption Analysis by Top Regions

    • 5.3 Europe Meningococcal Vaccines Production, Import, Consumption and Export Analysis by Regions

      • 5.3.1 Germany Meningococcal Vaccines Production, Import, Consumption and Export Analysis

      • 5.3.2 UK Meningococcal Vaccines Production, Import, Consumption and Export Analysis

      • 5.3.3 France Meningococcal Vaccines Production, Import, Consumption and Export Analysis

      • 5.3.4 Italy Meningococcal Vaccines Production, Import, Consumption and Export Analysis

      • 5.3.5 Spain Meningococcal Vaccines Production, Import, Consumption and Export Analysis

      • 5.3.6 Poland Meningococcal Vaccines Production, Import, Consumption and Export Analysis

      • 5.3.7 Russia Meningococcal Vaccines Production, Import, Consumption and Export Analysis

      • 5.3.8 Switzerland Meningococcal Vaccines Production, Import, Consumption and Export Analysis

      • 5.3.9 Turkey Meningococcal Vaccines Production, Import, Consumption and Export Analysis

      • 5.3.10 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Meningococcal Vaccines Production, Import, Consumption and Export Analysis

      • 5.3.11 Benelux (Belgium, Netherlands, and Luxembourg) Meningococcal Vaccines Production, Import, Consumption and Export Analysis

      • 5.3.12 Baltic States (Estonia, Latvia, and Lithuania) Meningococcal Vaccines Production, Import, Consumption and Export Analysis

    6 Product Circulation of Meningococcal Vaccines Market among Top Countries

    • 6.1 Top 5 Export Countries in Meningococcal Vaccines Market from 2014 to 2019

      • 6.1.1 Top 5 Export Countries’ Export Value Analysis in Meningococcal Vaccines Market from 2014 to 2019

      • 6.1.2 Top 5 Export Countries’ Export Volume Analysis in Meningococcal Vaccines Market from 2014 to 2019

    • 6.2 Top 5 Import Countries in Meningococcal Vaccines Market from 2014 to 2019

      • 6.2.1 Top 5 Import Countries’ Import Value Analysis in Meningococcal Vaccines Market from 2014 to 2019

      • 6.2.2 Top 5 Import Countries’ Import Volume Analysis in Meningococcal Vaccines Market from 2014 to 2019

    • 6.3 Emerging Top 3 Export Countries Analysis

    • 6.4 Emerging Top 3 Import Countries Analysis

    7. Germany Meningococcal Vaccines Landscape Analysis

    • 7.1 Germany Meningococcal Vaccines Landscape Analysis by Major Types

    • 7.2 Germany Meningococcal Vaccines Landscape Analysis by Major End-Users

    8. UK Meningococcal Vaccines Landscape Analysis

    • 8.1 UK Meningococcal Vaccines Landscape Analysis by Major Types

    • 8.2 UK Meningococcal Vaccines Landscape Analysis by Major End-Users

    9. France Meningococcal Vaccines Landscape Analysis

    • 9.1 France Meningococcal Vaccines Landscape Analysis by Major Types

    • 9.2 France Meningococcal Vaccines Landscape Analysis by Major End-Users

    10. Italy Meningococcal Vaccines Landscape Analysis

    • 10.1 Italy Meningococcal Vaccines Landscape Analysis by Major Types

    • 10.2 Italy Meningococcal Vaccines Landscape Analysis by Major End-Users

    11. Spain Meningococcal Vaccines Landscape Analysis

    • 11.1 Spain Meningococcal Vaccines Landscape Analysis by Major Types

    • 11.2 Spain Meningococcal Vaccines Landscape Analysis by Major End-Users

    12. Poland Meningococcal Vaccines Landscape Analysis

    • 12.1 Poland Meningococcal Vaccines Landscape Analysis by Major Types

    • 12.2 Poland Meningococcal Vaccines Landscape Analysis by Major End-Users

    13. Russia Meningococcal Vaccines Landscape Analysis

    • 13.1 Russia Meningococcal Vaccines Landscape Analysis by Major Types

    • 13.2 Russia Meningococcal Vaccines Landscape Analysis by Major End-Users

    14. Switzerland Meningococcal Vaccines Landscape Analysis

    • 14.1 Switzerland Meningococcal Vaccines Landscape Analysis by Major Types

    • 14.2 Switzerland Meningococcal Vaccines Landscape Analysis by Major End-Users

    15. Turkey Meningococcal Vaccines Landscape Analysis

    • 15.1 Turkey Meningococcal Vaccines Landscape Analysis by Major Types

    • 15.2 Turkey Meningococcal Vaccines Landscape Analysis by Major End-Users

    16. Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Meningococcal Vaccines Landscape Analysis

    • 16.1 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Meningococcal Vaccines Landscape Analysis by Major Types

    • 16.2 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Meningococcal Vaccines Landscape Analysis by Major End-Users

    • 16.3 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Meningococcal Vaccines Landscape Analysis by Top Countries

      • 16.3.1 Denmark Meningococcal Vaccines Market Volume and Growth Rate

      • 16.3.2 Finland Meningococcal Vaccines Market Volume and Growth Rate

      • 16.3.3 Norway Meningococcal Vaccines Market Volume and Growth Rate

      • 16.3.4 Sweden Meningococcal Vaccines Market Volume and Growth Rate

      • 16.3.6 Iceland Meningococcal Vaccines Market Volume and Growth Rate

    17 Benelux (Belgium, Netherlands, and Luxembourg) Meningococcal Vaccines Landscape Analysis

    • 17.1 Benelux (Belgium, Netherlands, and Luxembourg) Meningococcal Vaccines Landscape Analysis by Major Types

    • 17.2 Benelux (Belgium, Netherlands, and Luxembourg) Meningococcal Vaccines Landscape Analysis by Major End-Users

    • 17.3 Benelux (Belgium, Netherlands, and Luxembourg) Meningococcal Vaccines Landscape Analysis by Top Countries

      • 17.3.1 Belgium Meningococcal Vaccines Market Volume and Growth Rate

      • 17.3.2 Netherlands Meningococcal Vaccines Market Volume and Growth Rate

      • 17.3.3 Luxembourg Meningococcal Vaccines Market Volume and Growth Rate

    18 Baltic States (Estonia, Latvia, and Lithuania) Meningococcal Vaccines Landscape Analysis

    • 18.1 Baltic States (Estonia, Latvia, and Lithuania) Meningococcal Vaccines Landscape Analysis by Major Types

    • 18.2 Baltic States (Estonia, Latvia, and Lithuania) Meningococcal Vaccines Landscape Analysis by Major End-Users

    • 18.3 Baltic States (Estonia, Latvia, and Lithuania) Meningococcal Vaccines Landscape Analysis by Top Countries

      • 18.3.1 Estonia Meningococcal Vaccines Market Volume and Growth Rate

      • 18.3.2 Latvia Meningococcal Vaccines Market Volume and Growth Rate

      • 18.3.3 Lithuania Meningococcal Vaccines Market Volume and Growth Rate

    19 Major Players Profiles

    • 19.1 Sanofi

      • 19.1.1 Sanofi Company Profile and Development Status

      • 19.1.2 Market Performance

      • 19.1.3 Product and Service Introduction

    • 19.2 Pfizer

      • 19.2.1 Pfizer Company Profile and Development Status

      • 19.2.2 Market Performance

      • 19.2.3 Product and Service Introduction

    • 19.3 Baxter International

      • 19.3.1 Baxter International Company Profile and Development Status

      • 19.3.2 Market Performance

      • 19.3.3 Product and Service Introduction

    • 19.4 JN-International Medical

      • 19.4.1 JN-International Medical Company Profile and Development Status

      • 19.4.2 Market Performance

      • 19.4.3 Product and Service Introduction

    • 19.5 Novartis International

      • 19.5.1 Novartis International Company Profile and Development Status

      • 19.5.2 Market Performance

      • 19.5.3 Product and Service Introduction

    • 19.6 GlaxoSmithKline

      • 19.6.1 GlaxoSmithKline Company Profile and Development Status

      • 19.6.2 Market Performance

      • 19.6.3 Product and Service Introduction

    The List of Tables and Figures (Totals 77 Figures and 184 Tables)

    • Figure Product Picture

    • Figure Meningococcal Vaccines Market Size and Growth Rate of Menactra Market, 2015 - 2026 (USD Million)

    • Figure Meningococcal Vaccines Market Size and Growth Rate of Menomune Market, 2015 - 2026 (USD Million)

    • Figure Meningococcal Vaccines Market Size and Growth Rate of Pneumonia from 2014 to 2026

    • Figure Meningococcal Vaccines Market Size and Growth Rate of Meningitis from 2014 to 2026

    • Figure Meningococcal Vaccines Market Size and Growth Rate of Bacteremia from 2014 to 2026

    • Figure Meningococcal Vaccines Market Size and Growth Rate of Others (Arthritis, Conjunctivitis, Urethritis) from 2014 to 2026

    • Figure Germany Meningococcal Vaccines Market Size and Growth Rate from 2014 to 2026

    • Figure UK Meningococcal Vaccines Market Size and Growth Rate from 2014 to 2026

    • Figure France Meningococcal Vaccines Market Size and Growth Rate from 2014 to 2026

    • Figure Italy Meningococcal Vaccines Market Size and Growth Rate from 2014 to 2026

    • Figure Spain Meningococcal Vaccines Market Size and Growth Rate from 2014 to 2026

    • Figure Poland Meningococcal Vaccines Market Size and Growth Rate from 2014 to 2026

    • Figure Russia Meningococcal Vaccines Market Size and Growth Rate from 2014 to 2026

    • Figure Switzerland Meningococcal Vaccines Market Size and Growth Rate from 2014 to 2026

    • Figure Turkey Meningococcal Vaccines Market Size and Growth Rate from 2014 to 2026

    • Figure Canada Meningococcal Vaccines Market Size and Growth Rate from 2014 to 2026

    • Figure Mexico Meningococcal Vaccines Market Size and Growth Rate from 2014 to 2026

    • Figure Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Meningococcal Vaccines Market Size and Growth Rate from 2014 to 2026

    • Figure Denmark Meningococcal Vaccines Market Size and Growth Rate from 2014 to 2026

    • Figure Finland Meningococcal Vaccines Market Size and Growth Rate from 2014 to 2026

    • Figure Norway Meningococcal Vaccines Market Size and Growth Rate from 2014 to 2026

    • Figure Sweden Meningococcal Vaccines Market Size and Growth Rate from 2014 to 2026

    • Figure Iceland Meningococcal Vaccines Market Size and Growth Rate from 2014 to 2026

    • Figure Benelux (Belgium, Netherlands, and Luxembourg) Meningococcal Vaccines Market Size and Growth Rate from 2014 to 2026

    • Figure Belgium Meningococcal Vaccines Market Size and Growth Rate from 2014 to 2026

    • Figure Netherlands Meningococcal Vaccines Market Size and Growth Rate from 2014 to 2026

    • Figure Luxembourg Meningococcal Vaccines Market Size and Growth Rate from 2014 to 2026

    • Figure Baltic States (Estonia, Latvia, and Lithuania) Meningococcal Vaccines Market Size and Growth Rate from 2014 to 2026

    • Figure Estonia Meningococcal Vaccines Market Size and Growth Rate from 2014 to 2026

    • Figure Latvia Meningococcal Vaccines Market Size and Growth Rate from 2014 to 2026

    • Figure Lithuania Meningococcal Vaccines Market Size and Growth Rate from 2014 to 2026

    • Figure Development Trends and Industry Dynamics of Meningococcal Vaccines Industry

    • Figure Market Challenges and Restraints

    • Figure Market Opportunities and Potentials

    • Table Mergers and Acquisition

    • Figure Market Share of TOP 6 Players from 2014 to 2019

    • Figure Porter's Five Forces Analysis

    • Figure New Entrant SWOT Analysis

    • Table Specifications of Different Types of Meningococcal Vaccines

    • Figure Development Trends of Different Types

    • Table Commercial Products Types of Major Vendors

    • Figure Competitive Landscape Analysis of Different Types

    • Table Consumption of Meningococcal Vaccines by Different Types from 2014 to 2026

    • Table Consumption Share of Meningococcal Vaccines by Different Types from 2014 to 2026

    • Figure Meningococcal Vaccines Market Size and Growth Rate of Menactra Market, 2015 - 2026 (USD Million)

    • Figure Meningococcal Vaccines Market Size and Growth Rate of Menomune Market, 2015 - 2026 (USD Million)

    • Table Downstream Client Analysis by End-Users

    • Figure Competitive Landscape Analysis of Different End-Users

    • Table Market Potential Analysis of Different End-Users

    • Table Consumption of Meningococcal Vaccines by Different End-Users from 2014 to 2026

    • Table Consumption Share of Meningococcal Vaccines by Different End-Users from 2014 to 2026

    • Figure Meningococcal Vaccines Market Size and Growth Rate of Pneumonia from 2014 to 2026

    • Figure Meningococcal Vaccines Market Size and Growth Rate of Meningitis from 2014 to 2026

    • Figure Meningococcal Vaccines Market Size and Growth Rate of Bacteremia from 2014 to 2026

    • Figure Meningococcal Vaccines Market Size and Growth Rate of Others (Arthritis, Conjunctivitis, Urethritis) from 2014 to 2026

    • Table Europe Meningococcal Vaccines Production by Major Regions

    • Table Europe Meningococcal Vaccines Production Share by Major Regions

    • Figure Europe Meningococcal Vaccines Production Share by Major Countries and Regions in 2014

    • Table Europe Meningococcal Vaccines Consumption by Major Regions

    • Table Europe Meningococcal Vaccines Consumption Share by Major Regions

    • Table Germany Meningococcal Vaccines Production, Import, Consumption and Export Analysis

    • Table UK Meningococcal Vaccines Production, Import, Consumption and Export Analysis

    • Table France Meningococcal Vaccines Production, Import, Consumption and Export Analysis

    • Table Italy Meningococcal Vaccines Production, Import, Consumption and Export Analysis

    • Table Spain Meningococcal Vaccines Production, Import, Consumption and Export Analysis

    • Table Poland Meningococcal Vaccines Production, Import, Consumption and Export Analysis

    • Table Russia Meningococcal Vaccines Production, Import, Consumption and Export Analysis

    • Table Switzerland Meningococcal Vaccines Production, Import, Consumption and Export Analysis

    • Table Turkey Meningococcal Vaccines Production, Import, Consumption and Export Analysis

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Meningococcal Vaccines Production, Import, Consumption and Export Analysis

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Meningococcal Vaccines Production, Import, Consumption and Export Analysis

    • Table Baltic States (Estonia, Latvia, and Lithuania) Meningococcal Vaccines Production, Import, Consumption and Export Analysis

    • Table Top 5 Export Countries' Export Value Analysis in Meningococcal Vaccines Market from 2014 to 2019

    • Table Top 5 Export Countries' Export Volume Analysis in Meningococcal Vaccines Market from 2014 to 2019

    • Table Top 5 Import Countries' Import Value Analysis in Meningococcal Vaccines Market from 2014 to 2019

    • Table Top 5 Import Countries' Import Volume Analysis in Meningococcal Vaccines Market from 2014 to 2019

    • Figure Emerging Top 3 Export Countries Analysis

    • Figure Emerging Top 3 Import Countries Analysis

    • Table Germany Meningococcal Vaccines Consumption by Types from 2014 to 2026

    • Table Germany Meningococcal Vaccines Consumption Share by Types from 2014 to 2026

    • Table Germany Meningococcal Vaccines Consumption by End-Users from 2014 to 2026

    • Table Germany Meningococcal Vaccines Consumption Share by End-Users from 2014 to 2026

    • Table UK Meningococcal Vaccines Consumption by Types from 2014 to 2026

    • Table UK Meningococcal Vaccines Consumption Share by Types from 2014 to 2026

    • Table UK Meningococcal Vaccines Consumption by End-Users from 2014 to 2026

    • Table UK Meningococcal Vaccines Consumption Share by End-Users from 2014 to 2026

    • Table France Meningococcal Vaccines Consumption by Types from 2014 to 2026

    • Table France Meningococcal Vaccines Consumption Share by Types from 2014 to 2026

    • Table France Meningococcal Vaccines Consumption by End-Users from 2014 to 2026

    • Table France Meningococcal Vaccines Consumption Share by End-Users from 2014 to 2026

    • Table Italy Meningococcal Vaccines Consumption by Types from 2014 to 2026

    • Table Italy Meningococcal Vaccines Consumption Share by Types from 2014 to 2026

    • Table Italy Meningococcal Vaccines Consumption by End-Users from 2014 to 2026

    • Table Italy Meningococcal Vaccines Consumption Share by End-Users from 2014 to 2026

    • Table Spain Meningococcal Vaccines Consumption by Types from 2014 to 2026

    • Table Spain Meningococcal Vaccines Consumption Share by Types from 2014 to 2026

    • Table Spain Meningococcal Vaccines Consumption by End-Users from 2014 to 2026

    • Table Spain Meningococcal Vaccines Consumption Share by End-Users from 2014 to 2026

    • Table Poland Meningococcal Vaccines Consumption by Types from 2014 to 2026

    • Table Poland Meningococcal Vaccines Consumption Share by Types from 2014 to 2026

    • Table Poland Meningococcal Vaccines Consumption by End-Users from 2014 to 2026

    • Table Poland Meningococcal Vaccines Consumption Share by End-Users from 2014 to 2026

    • Table Russia Meningococcal Vaccines Consumption by Types from 2014 to 2026

    • Table Russia Meningococcal Vaccines Consumption Share by Types from 2014 to 2026

    • Table Russia Meningococcal Vaccines Consumption by End-Users from 2014 to 2026

    • Table Russia Meningococcal Vaccines Consumption Share by End-Users from 2014 to 2026

    • Table Switzerland Meningococcal Vaccines Consumption by Types from 2014 to 2026

    • Table Switzerland Meningococcal Vaccines Consumption Share by Types from 2014 to 2026

    • Table Switzerland Meningococcal Vaccines Consumption by End-Users from 2014 to 2026

    • Table Switzerland Meningococcal Vaccines Consumption Share by End-Users from 2014 to 2026

    • Table Turkey Meningococcal Vaccines Consumption by Types from 2014 to 2026

    • Table Turkey Meningococcal Vaccines Consumption Share by Types from 2014 to 2026

    • Table Turkey Meningococcal Vaccines Consumption by End-Users from 2014 to 2026

    • Table Turkey Meningococcal Vaccines Consumption Share by End-Users from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Meningococcal Vaccines Consumption by Types from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Meningococcal Vaccines Consumption Share by Types from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Meningococcal Vaccines Consumption by End-Users from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Meningococcal Vaccines Consumption Share by End-Users from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Meningococcal Vaccines Consumption by Major Countries from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Meningococcal Vaccines Consumption Share by Major Countries from 2014 to 2026

    • Figure Denmark Meningococcal Vaccines Market Volume and Growth Rate from 2014 to 2026

    • Figure Finland Meningococcal Vaccines Market Volume and Growth Rate from 2014 to 2026

    • Figure Norway Meningococcal Vaccines Market Volume and Growth Rate from 2014 to 2026

    • Figure Sweden Meningococcal Vaccines Market Volume and Growth Rate from 2014 to 2026

    • Figure Iceland Meningococcal Vaccines Market Volume and Growth Rate from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Meningococcal Vaccines Consumption by Types from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Meningococcal Vaccines Consumption Share by Types from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Meningococcal Vaccines Consumption by End-Users from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Meningococcal Vaccines Consumption Share by End-Users from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Meningococcal Vaccines Consumption by Major Countries from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Meningococcal Vaccines Consumption Share by Major Countries from 2014 to 2026

    • Figure Belgium Meningococcal Vaccines Market Volume and Growth Rate from 2014 to 2026

    • Figure Netherlands Meningococcal Vaccines Market Volume and Growth Rate from 2014 to 2026

    • Figure Luxembourg Meningococcal Vaccines Market Volume and Growth Rate from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Meningococcal Vaccines Consumption by Types from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Meningococcal Vaccines Consumption Share by Types from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Meningococcal Vaccines Consumption by End-Users from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Meningococcal Vaccines Consumption Share by End-Users from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Meningococcal Vaccines Consumption by Major Countries from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Meningococcal Vaccines Consumption Share by Major Countries from 2014 to 2026

    • Figure Estonia Meningococcal Vaccines Market Volume and Growth Rate from 2014 to 2026

    • Figure Latvia Meningococcal Vaccines Market Volume and Growth Rate from 2014 to 2026

    • Figure Lithuania Countries Meningococcal Vaccines Market Volume and Growth Rate from 2014 to 2026

    • Table Sanofi Profiles

    • Table Sanofi Production, Value, Price, Gross Margin 2014-2019

    • Table Sanofi Product benchmarking

    • Table Sanofi Strategic initiatives

    • Table Sanofi SWOT analysis

    • Table Pfizer Profiles

    • Table Pfizer Production, Value, Price, Gross Margin 2014-2019

    • Table Pfizer Product benchmarking

    • Table Pfizer Strategic initiatives

    • Table Pfizer SWOT analysis

    • Table Baxter International Profiles

    • Table Baxter International Production, Value, Price, Gross Margin 2014-2019

    • Table Baxter International Product benchmarking

    • Table Baxter International Strategic initiatives

    • Table Baxter International SWOT analysis

    • Table JN-International Medical Profiles

    • Table JN-International Medical Production, Value, Price, Gross Margin 2014-2019

    • Table JN-International Medical Product benchmarking

    • Table JN-International Medical Strategic initiatives

    • Table JN-International Medical SWOT analysis

    • Table Novartis International Profiles

    • Table Novartis International Production, Value, Price, Gross Margin 2014-2019

    • Table Novartis International Product benchmarking

    • Table Novartis International Strategic initiatives

    • Table Novartis International SWOT analysis

    • Table GlaxoSmithKline Profiles

    • Table GlaxoSmithKline Production, Value, Price, Gross Margin 2014-2019

    • Table GlaxoSmithKline Product benchmarking

    • Table GlaxoSmithKline Strategic initiatives

    • Table GlaxoSmithKline SWOT analysis

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US